From state to function: macrophage–microenvironment interactions and therapeutic strategies in skin fibrosis

Skin fibrosis occurs in conditions such as systemic sclerosis, pathological scarring, radiation-induced skin injury, and chronic graft-versus-host disease. Its core pathological processes include aberrant fibroblast activation and excessive extracellular matrix deposition. Macrophages participate in the clearance of necrotic tissue, resolution of inflammation, and matrix remodeling, but can also promote fibroblast activation and collagen deposition in specific pathological environments. Their roles are jointly influenced by disease stage, tissue distribution, and the local mechanical and metabolic environment. This review examines the roles of macrophages in skin repair and fibrosis, focusing on microenvironmental regulation, intercellular interactions, and related therapeutic research. It also draws on advances in lactate transport, epigenetic regulation, and matrix clearance to analyze changes in macrophage function and their implications for intervention. Macrophages with repair-associated features can also promote fibrosis, and reported functional effects vary with the experimental system and the outcome assessed. Therefore, therapeutic target selection cannot rely solely on the M1/M2 classification, but must also consider the specific effects of macrophages on inflammation, matrix deposition, and matrix degradation. Current research centers on the regulation of pathological inflammation and metabolism, while also seeking to preserve inflammatory resolution, matrix clearance, and normal repair, and to use delivery systems to improve local effects and the timing of intervention. Most approaches remain preclinical, although colony-stimulating factor 1 receptor (CSF-1R) blockade with axatilimab has progressed to an approved treatment for previously treated chronic graft-versus-host disease (cGVHD). Clinical translation requires distinguishing fibrosis prevention from the treatment of established lesions and assessing not only the extent of fibrosis but also tissue architecture and mechanical properties, symptoms, function, and recurrence.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.2014946
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From state to function: macrophage–microenvironment interactions and therapeutic strategies in skin fibrosis

Haiyan Qin, Zhenhao Zhang, Mingxi Li, Lianbo Zhang
2 links
Frontiers in Immunology
Systemic Sclerosis and Related Diseases
article

From state to function: macrophage–microenvironment interactions and therapeutic strategies in skin fibrosis

Haiyan Qin, Zhenhao Zhang, Mingxi Li, Lianbo Zhang
article en

Abstract

Skin fibrosis occurs in conditions such as systemic sclerosis, pathological scarring, radiation-induced skin injury, and chronic graft-versus-host disease. Its core pathological processes include aberrant fibroblast activation and excessive extracellular matrix deposition. Macrophages participate in the clearance of necrotic tissue, resolution of inflammation, and matrix remodeling, but can also promote fibroblast activation and collagen deposition in specific pathological environments. Their roles are jointly influenced by disease stage, tissue distribution, and the local mechanical and metabolic environment. This review examines the roles of macrophages in skin repair and fibrosis, focusing on microenvironmental regulation, intercellular interactions, and related therapeutic research. It also draws on advances in lactate transport, epigenetic regulation, and matrix clearance to analyze changes in macrophage function and their implications for intervention. Macrophages with repair-associated features can also promote fibrosis, and reported functional effects vary with the experimental system and the outcome assessed. Therefore, therapeutic target selection cannot rely solely on the M1/M2 classification, but must also consider the specific effects of macrophages on inflammation, matrix deposition, and matrix degradation. Current research centers on the regulation of pathological inflammation and metabolism, while also seeking to preserve inflammatory resolution, matrix clearance, and normal repair, and to use delivery systems to improve local effects and the timing of intervention. Most approaches remain preclinical, although colony-stimulating factor 1 receptor (CSF-1R) blockade with axatilimab has progressed to an approved treatment for previously treated chronic graft-versus-host disease (cGVHD). Clinical translation requires distinguishing fibrosis prevention from the treatment of established lesions and assessing not only the extent of fibrosis but also tissue architecture and mechanical properties, symptoms, function, and recurrence.

Frontiers in ImmunologyVol. 17
Jilin University (CN)
Jilin Scientific and Technological Development Program
Good health and well-being
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon